Inactive Instrument

Dragonfly Biosciences Limited

Equities

DRF

AU0000178733

Dragonfly Biosciences Limited Reports Earnings Results for the Eighteen Months Ended June 30, 2022

April 15, 2023

Dragonfly Biosciences Limited reported earnings results for the eighteen months ended June 30, 2022. For the eighteen months, the company reported sales was GBP 2.41 million. Net loss was GBP 3.74 million.

Latest news about Dragonfly Biosciences Limited

Dragonfly Biosciences Limited Auditor Raises 'Going Concern' Doubt	15/23/15	CI
Dragonfly Biosciences Limited Reports Earnings Results for the Eighteen Months Ended June 30, 2022	15/23/15	CI
Dragonfly Biosciences Limited has withdrawn its IPO in the amount of AUD 11 million.	18/22/18	CI
Dragonfly Biosciences Enters into USA Trading Agreement with Thought Leaders Inc	18/22/18	CI
Dragonfly Biosciences Limited has filed an IPO in the amount of AUD 11 million.	07/21/07	CI
Dragonfly Biosciences UK Announces Further Global Expansion Across Asia With eCargo Holdings	17/21/17	CI
Health House International Limited Signs Distribution Agreement with Dragonfly Biosciences Limited	21/21/21	CI
Dragonfly Biosciences Terminates Venture Agreement with Borganic Inc/Stillcanna Inc	04/20/04	CI

Chart Dragonfly Biosciences Limited

Duration

Period

More charts

Company Profile

Sector

More about the company